Minneapolis Clinical Trials
Modulator Study (SAD)
Purpose: to evaluate the safety and tolerability of an investigational medication for cystic fibrosis.
3 nights
1 visits
Participate in a clinical study of a potential new treatment for cystic fibrosis.
Reimbursement for study participation will be provided for time of up to $1,482.
This study requires one inpatient stay of 3 nights / 4 days and 1 follow up phone call.
This study has been reviewed and approved by an independent ethics committee.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-55
BMI: 18-32kg/m2
Medications: No current over the counter or prescribed medications
Smoking Status: Non-smokers
Compensation: Up to $1,482 for study completion